These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17205524)

  • 41. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
    Gunawardena K; Campbell LD; Meikle AW
    Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Segal CV; Koufaris C; Powell C; Gooderham NJ
    Toxicology; 2015 Jul; 333():45-52. PubMed ID: 25846647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogenic herpesvirus HHV-8 promotes androgen-independent prostate cancer growth.
    Mygatt JG; Singhal A; Sukumar G; Dalgard CL; Kaleeba JA
    Cancer Res; 2013 Sep; 73(18):5695-708. PubMed ID: 24005834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
    Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR
    Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
    Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
    Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
    Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS
    Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells.
    Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT
    Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ethanolic extracts of herbal supplement Equiguard suppress growth and control gene expression in CWR22Rv1 cells representing the transition of prostate cancer from androgen dependence to hormone refractory status.
    Hsieh TC; Wu JM
    Int J Oncol; 2008 Jan; 32(1):209-19. PubMed ID: 18097561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
    Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
    Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
    Facompre ND; Sinha I; El-Bayoumy K; Pinto JT; Sinha R
    Int J Cancer; 2012 Nov; 131(9):2134-42. PubMed ID: 22307455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
    Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
    Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
    Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).
    Bonaccorsi L; Carloni V; Muratori M; Formigli L; Zecchi S; Forti G; Baldi E
    Int J Cancer; 2004 Oct; 112(1):78-86. PubMed ID: 15305378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
    Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM
    J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies.
    Hsieh TC; Lu X; Guo J; Xiong W; Kunicki J; Darzynkiewicz Z; Wu JM
    Int J Oncol; 2002 Apr; 20(4):681-9. PubMed ID: 11894110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
    Kim SH; Singh SV
    Mol Cancer Ther; 2009 Jul; 8(7):1946-54. PubMed ID: 19584240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.